Currently predicting for Thu, 4 Jun 2026

NKTX Prediction Chart

NKTX Predictions History

Latest community submissions for NKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 9, 2026 $2.57 +2.79% $2.58 V 99.61% 5
Mar 9, 2026 $2.54 +1.75% $2.58 V 98.59% 2
Feb 27, 2026 $2.56 -2.22% $2.70 X 94.88% 0
Feb 27, 2026 $2.58 -1.39% $2.70 X 95.69% 0
Apr 29, 2025 $2.08 +3.40% $1.95 X 93.42% 0
Apr 29, 2025 $1.97 -2.13% $1.95 V 99.11% 3
Apr 29, 2025 Bearish $1.95 V 1
Jan 16, 2025 $2.31 +3.01% $2.49 V 92.67% 1
Jan 16, 2025 $2.28 +1.88% $2.49 V 91.65% 1
Jan 16, 2025 Bearish $2.49 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NKARTA INC.
Nkarta
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE